Refine
Has Fulltext
- yes (41)
Is part of the Bibliography
- yes (41)
Year of publication
Document Type
- Journal article (41) (remove)
Language
- English (41)
Keywords
- T cells (3)
- fear conditioning (3)
- near-infrared spectroscopy (3)
- phosphoantigen (3)
- working memory (3)
- BTN3 (2)
- CML (2)
- COVID-19 (2)
- CXCR4 (2)
- FMRI (2)
- LASP1 (2)
- activation (2)
- alpaca (2)
- butyrophilin (2)
- butyrophilin 3 (2)
- cell staining (2)
- electroencephalography (2)
- evolution (2)
- fMRI (2)
- glioblastoma multiforme (2)
- reaction time (2)
- transcranial direct current stimulation (2)
- γδ T cell (2)
- ABCG2 (1)
- ADHD (1)
- AKT1 (1)
- ARDS (acute respiratory distress syndrome) (1)
- AcrAB-TolC efflux pump (1)
- Alzheimer's disease (1)
- Alzheimers disease (1)
- Alzheimer’s disease (1)
- BCR‐ABL (1)
- BTN (1)
- BTN2 (1)
- BTN2A1 (1)
- BTN3A1 (1)
- CD3/19 depletion (1)
- CD34 selection (1)
- Couch tracking (1)
- DETC (1)
- DNA damage (1)
- Dendritische Zelle (1)
- FNIRS (1)
- Germany (1)
- Gimbaled tracking (1)
- Krebs <Medizin> (1)
- MLC tracking (1)
- Munigua (1)
- NIRS (1)
- NPU (1)
- NRF2 (1)
- Organ motion (1)
- RTMS (1)
- Robotic tracking (1)
- Schlaganfall (1)
- Skint1 (1)
- T cell receptor (1)
- TRDV2 (1)
- TRGV9 (1)
- Vγ9Vδ2 (1)
- Vγ9Vδ2 T cell (1)
- \(^{68}\)Ga-Pentixafor (1)
- adult attention deficit/hyperactivity disorder (1)
- allogeneic stem cell transplantation (1)
- analysis of variance (1)
- anticipatory anxiety (1)
- antigen (1)
- antigen presentation (1)
- anxiety (1)
- apolipoprotein-E4 (1)
- assay (1)
- association (1)
- atypical tetracyclines (1)
- auditory cortex (1)
- basal ganglia (1)
- binding analysis (1)
- blood coagulation (1)
- bold (1)
- brain (1)
- brain stimulation (1)
- brain-regions (1)
- breast cancer (1)
- broad-spectrum antibiotics (1)
- butyrophilin 2A1 (1)
- butyrophilins (1)
- cells (1)
- chelocardins (1)
- chemokine receptor-4 (1)
- child memory (1)
- children (1)
- clinical isolates (1)
- clinical trial (1)
- co-evolution (1)
- coevolution (1)
- cognitive decline (1)
- cognitive impairment (1)
- cortical activation (1)
- cytome biomarkers (1)
- cytotoxic T cells (1)
- dementia (1)
- dendric cells (1)
- diagnosis (1)
- dopamine (1)
- dopaminergics (1)
- dorsolateral prefrontal cortex (1)
- early-onset predictors (1)
- elderly (1)
- electrode recording (1)
- emotional regulation (1)
- emotions (1)
- eyes (1)
- factor XII (1)
- fear memory consolidation (1)
- fluorescence-activated cell sorting (1)
- functional magnetic resonance imaging (1)
- gammadelta T cells (1)
- geomorphology (1)
- glioblastoma (1)
- glioma (1)
- glycolipids (1)
- haplotypes (1)
- human (1)
- humans (1)
- imaging (1)
- immune reconstitution (1)
- immune therapy (1)
- immunostaining (1)
- immunosurveillance (1)
- individual differences (1)
- intelligibility (1)
- intensive care medicine (1)
- interleukins (1)
- land use (1)
- learning (1)
- life (1)
- lipids (1)
- liquid biopsy (1)
- lymph nodes (1)
- lymphomas (1)
- machine learning (1)
- macrophages (1)
- magnetic resonance imaging (1)
- major histocompatibility complex (1)
- mechanism of resistance (1)
- medial prefrontal cortex (mPFC) (1)
- medicine (1)
- memory consolidation and extinction (1)
- mental arithmetic (1)
- metastasis-associated in colon cancer 1 (MACC1) (1)
- methylphenidate (1)
- mevalonate pathway (1)
- microglial cells (1)
- mild cognitive impairment (1)
- mouse models (1)
- multilocularis (1)
- neural activity (1)
- neuroinflammation (1)
- neurological complications (1)
- neurology (1)
- nilotinib (1)
- nine-banded armadillo (1)
- oligomers (1)
- oxygen consumption (1)
- pandemia (1)
- peripheral-blood lymphocytes (1)
- phasic threat responding (1)
- phosphoantigens (1)
- placental mammals (1)
- positron emission tomography (1)
- positron emission tomography/computed tomography (1)
- positron-emission-tomography (1)
- precursor cells (1)
- prefrontal cortex (1)
- prevention (1)
- prognostic marker (1)
- psychiatry (1)
- research errors (1)
- resistance-breaking properties (1)
- right inferior frontalgyrus (1)
- short-term methylphenidate brain (1)
- skin conduction response (1)
- somatostatin (1)
- spider phobia (1)
- subsctraction (1)
- surfactants (1)
- sustained fear (1)
- sustained threat responding (1)
- tDCS (1)
- task difficulty (1)
- theranostic markers (1)
- therapy response (1)
- transcranial magnetic stimulation (1)
- transcranial magnetic stimulation (TMS) (1)
- tumor (1)
- urinary tract infection (UTI) (1)
- uropathogens (1)
- ventromedial prefrontal cortex (1)
- verbal fluency task (1)
- γδ T cells (1)
- γδ TCR (1)
Institute
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (15)
- Institut für Virologie und Immunbiologie (11)
- Neurologische Klinik und Poliklinik (4)
- Institut für Psychologie (3)
- Neurochirurgische Klinik und Poliklinik (3)
- Rudolf-Virchow-Zentrum (3)
- Institut für Experimentelle Biomedizin (2)
- Kinderklinik und Poliklinik (2)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (2)
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (2)
EU-Project number / Contract (GA) number
- 641833 (1)
Butyrophilin (BTN)–3A and BTN2A1 molecules control the activation of human Vγ9Vδ2 T cells during T cell receptor (TCR)-mediated sensing of phosphoantigens (PAg) derived from microbes and tumors. However, the molecular rules governing PAg sensing remain largely unknown. Here, we establish three mechanistic principles of PAg-mediated γδ T cell activation. First, in humans, following PAg binding to the intracellular BTN3A1-B30.2 domain, Vγ9Vδ2 TCR triggering involves the extracellular V-domain of BTN3A2/BTN3A3. Moreover, the localization of both protein domains on different chains of the BTN3A homo-or heteromers is essential for efficient PAg-mediated activation. Second, the formation of BTN3A homo-or heteromers, which differ in intracellular trafficking and conformation, is controlled by molecular interactions between the juxtamembrane regions of the BTN3A chains. Finally, the ability of PAg not simply to bind BTN3A-B30.2, but to promote its subsequent interaction with the BTN2A1-B30.2 domain, is essential for T-cell activation. Defining these determinants of cooperation and the division of labor in BTN proteins improves our understanding of PAg sensing and elucidates a mode of action that may apply to other BTN family members.